EUCTR2010-024644-15-IT进行中（未招募）不适用
Concomitant therapy with levofloxacyn versus sequential therapy with levofloxacin for eradication of H. pylori infection
AZIENDA OSPEDALIERA UNIVERSITARIA DELLA SECONDA UNIVERSITA' DEGLI STUDI DI NAPOLI0 个研究点开始时间: 2012年3月20日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •We will enroll, after obtaining informed consent, subjects of age 18 or more, male and female, infected with H. pylori as assessed by invasive (histology and/or RUT) or noninvasive (13C Urea Breath Test (UBT) and stool antigen) tests.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Allergy or controindication to penicillin, quinolones, nitroimidazole compounds or PPI, pregnancy and under age.
研究者
相似试验
招募中
1 期
Efficacy of levofloxacin and colistin inhalation form in treatment of pneumoniaVentilator associated pneumonia (VAP) caused by multidrug resistant pathogens.Ventilator associated pneumoniaJ95.851IRCT20100107003014N26Mazandaran University of Medical Sciences70
已完成
2 期
Comparing the effect of levofloxacin with azithromycin in improving pulmonary function of patients with bronchiectasisIRCT20100102002954N28Shahroud University of Medical Sciences72
进行中（未招募）
不适用
Prulifloxacino frente a levofloxacino en el tratamiento de pacientes con exacerbaciones agudas de bronquitis crónica (EABC)Exacerbación aguda de bronquitis crónicaEUCTR2006-004167-56-ESA.C.R.A.F. S.p.A.300
Unknown
4 期
Comparison of the Efficacy of Levofloxacin-based Sequential Therapy and Triple Therapy as Second Line TherapyEradication Rate for HelicobacterNCT01537055National Taiwan University Hospital600
已完成
2 期
Efficacy of Ofloxacin in eradication of Helicobacter pyloriHelicobacter Pylori Infection.Helicobacter pylori [H.pylori] as the cause of diseases classified to other chaptersIRCT2015113025292N1Vice chancellor for research, Babol University of Medical Sciences160